Market Overview:
The global hydroxychloroquine market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to exhibit robust growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Hydroxychloroquine (HCQ), with the chemical formula C18H26ClN3O, is a chemotherapeutic agent drug that is primarily used for the prevention and treatment of malaria. It acts against erythrocytic forms of malarial parasites and is majorly administered in the form of an oral tablet. It is also used for the treatment of various other diseases, such as systemic lupus erythematosus, rheumatoid arthritis, Q fever and Porphyria Cutanea Tarda (PCT) and is being examined for the possible treatment of the rapidly spreading COVID-19 disease. It exhibits immunosuppressive, anti-autophagy and antimalarial properties as it suppresses immune functions and presents antigens and cytokines in the body.
The sudden outbreak of the COVID-19 pandemic across the globe is one of the key factors driving the growth of the market. Various clinical trials and experiments are being conducted across the globe to analyze the efficacy and safety of hydroxychloroquine for the treatment of adults hospitalized with the coronavirus disease. The increasing prevalence of malaria and various other chronic diseases, especially in developing and underdeveloped countries, is also leading to the widespread adoption of this drug. In line with this, the rapidly rising cases of autoimmune diseases, such as lupus erythematosus and rheumatoid arthritis, are acting as another growth-inducing factor. Other factors, including the implementation of favorable government policies to promote global health, along with extensive research and development (R&D) activities in the field of medical sciences, are projected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global hydroxychloroquine market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on dosage type, distribution, application, grade and route of administration.
Breakup by Dosage Type:
- 200 Mg
- 300 Mg
- 400 Mg
- Others
Breakup by Distribution:
- Hospital Pharmacies
- Retail Pharmacies
- Others
Breakup by Application:
- Rheumatoid Arthritis
- Lupus Erythematosus
- Malaria
- Coronavirus (COVID-19)
- Others
Breakup by Grade:
- USP Standards Grade
- EP Standards Grade
- Pharmaceutical Standards Grade
- Others
Breakup by Route of Administration:
Breakup by Region:
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Amneal Pharmaceuticals Inc., Cardinal Health Inc., Cipla Ltd., Ipca Laboratories Ltd., Laurus Labs, Lupin Limited, Mylan N.V., Novartis AG, Prasco Laboratories, Dr. Reddy’s Laboratories Ltd., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Torrent Pharma, Zydus Cadila, etc.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2020 |
| Historical Period |
2015-2020 |
| Forecast Period |
2021-2026 |
| Units |
US$ Billion |
| Segment Coverage |
Dosage Type, Distribution, Application, Grade, Route of Administration, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Amneal Pharmaceuticals Inc., Cardinal Health Inc., Cipla Ltd., Ipca Laboratories Ltd., Laurus Labs, Lupin Limited, Mylan N.V., Novartis AG, Prasco Laboratories, Dr. Reddy’s Laboratories Ltd., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Torrent Pharma and Zydus Cadila |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global hydroxychloroquine market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global hydroxychloroquine market?
- What is the breakup of the market based on the dosage type?
- What is the breakup of the market based on the distribution?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the grade?
- What is the breakup of the market based on the route of administration?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global hydroxychloroquine market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Hydroxychloroquine Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Dosage Type
6.1 200 Mg
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 300 Mg
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 400 Mg
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Distribution
7.1 Hospital Pharmacies
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Retail Pharmacies
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Application
8.1 Rheumatoid Arthritis
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Lupus Erythematosus
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Malaria
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Coronavirus (COVID-19)
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Grade
9.1 USP Standards Grade
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 EP Standards Grade
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Pharmaceutical Standards Grade
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Route of Administration
10.1 Oral
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Intravenous
10.2.1 Market Trends
10.2.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Indicators
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Amneal Pharmaceuticals Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.2 Cardinal Health Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Cipla Ltd.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.4 Ipca Laboratories Ltd.
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.5 Laurus Labs
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.6 Lupin Limited
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 Mylan N.V.
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Novartis AG
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Prasco Laboratories
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.10 Dr. Reddy’s Laboratories Ltd.
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.10.4 SWOT Analysis
16.3.11 Sanofi S.A.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.11.4 SWOT Analysis
16.3.12 Teva Pharmaceutical Industries Ltd.
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.12.4 SWOT Analysis
16.3.13 Torrent Pharma
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
16.3.14 Zydus Cadila
16.3.14.1 Company Overview
16.3.14.2 Product Portfolio
List of Figures
Figure 1: Global: Hydroxychloroquine Market: Major Drivers and Challenges
Figure 2: Global: Hydroxychloroquine Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Hydroxychloroquine Market: Breakup by Dosage Type (in %), 2020
Figure 4: Global: Hydroxychloroquine Market: Breakup by Distribution (in %), 2020
Figure 5: Global: Hydroxychloroquine Market: Breakup by Application (in %), 2020
Figure 6: Global: Hydroxychloroquine Market: Breakup by Grade (in %), 2020
Figure 7: Global: Hydroxychloroquine Market: Breakup by Route of Administration (in %), 2020
Figure 8: Global: Hydroxychloroquine Market: Breakup by Region (in %), 2020
Figure 9: Global: Hydroxychloroquine Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 10: Global: Hydroxychloroquine (200 Mg) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Hydroxychloroquine (200 Mg) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Hydroxychloroquine (300 Mg) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Hydroxychloroquine (300 Mg) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Hydroxychloroquine (400 Mg) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Hydroxychloroquine (400 Mg) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Hydroxychloroquine (Other Dosage Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Hydroxychloroquine (Other Dosage Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Hydroxychloroquine (Hospital Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Hydroxychloroquine (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Hydroxychloroquine (Retail Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Hydroxychloroquine (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Hydroxychloroquine (Others) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Hydroxychloroquine (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Hydroxychloroquine (Rheumatoid Arthritis) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Hydroxychloroquine (Rheumatoid Arthritis) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Hydroxychloroquine (Lupus Erythematosus) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Hydroxychloroquine (Lupus Erythematosus) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Hydroxychloroquine (Malaria) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Hydroxychloroquine (Malaria) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Global: Hydroxychloroquine (Coronavirus- COVID-19) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Global: Hydroxychloroquine (Coronavirus- COVID-19) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Global: Hydroxychloroquine (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Global: Hydroxychloroquine (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Global: Hydroxychloroquine (USP Standards Grade) Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Global: Hydroxychloroquine (USP Standards Grade) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Global: Hydroxychloroquine (EP Standards Grade) Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Global: Hydroxychloroquine (EP Standards Grade) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Global: Hydroxychloroquine (Pharmaceutical Standards Grade) Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Global: Hydroxychloroquine (Pharmaceutical Standards Grade) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: Global: Hydroxychloroquine (Other Standards Grades) Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: Global: Hydroxychloroquine (Other Standards Grades) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Global: Hydroxychloroquine (Oral) Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Global: Hydroxychloroquine (Oral) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Global: Hydroxychloroquine (Intravenous) Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Global: Hydroxychloroquine (Intravenous) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: North America: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: North America: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: United States: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: United States: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Canada: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Canada: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Asia Pacific: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Asia Pacific: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: China: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: China: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Japan: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Japan: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: India: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: India: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: South Korea: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: South Korea: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Australia: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Australia: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Indonesia: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Indonesia: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Others: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Others: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Europe: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Europe: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Germany: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Germany: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: France: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: France: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: United Kingdom: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: United Kingdom: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Italy: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Italy: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 78: Spain: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 79: Spain: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 80: Russia: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 81: Russia: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 82: Others: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 83: Others: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 84: Latin America: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 85: Latin America: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 86: Brazil: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 87: Brazil: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 88: Mexico: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 89: Mexico: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 90: Others: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 91: Others: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 92: Middle East and Africa: Hydroxychloroquine Market: Sales Value (in Million US$), 2015 & 2020
Figure 93: Middle East and Africa: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 94: Global: Hydroxychloroquine Industry: SWOT Analysis
Figure 95: Global: Hydroxychloroquine Industry: Value Chain Analysis
Figure 96: Global: Hydroxychloroquine Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Hydroxychloroquine Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Hydroxychloroquine Market Forecast: Breakup by Dosage Type (in Million US$), 2021-2026
Table 3: Global: Hydroxychloroquine Market Forecast: Breakup by Distribution (in Million US$), 2021-2026
Table 4: Global: Hydroxychloroquine Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 5: Global: Hydroxychloroquine Market Forecast: Breakup by Grade (in Million US$), 2021-2026
Table 6: Global: Hydroxychloroquine Market Forecast: Breakup by Route of Administration (in Million US$), 2021-2026
Table 7: Global: Hydroxychloroquine Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 8: Global: Hydroxychloroquine Market Structure
Table 9: Global: Hydroxychloroquine Market: Key Players